CVS Health (CVS) says utilisation is expected to persist at elevated levels in 2026, although the level is difficult to accurately predict, beyond current levels it may pressure the health care benefits segment and health care delivery assets in 2026

CVS Health's guidance on elevated utilization suggests ongoing pressure on their healthcare benefits and delivery segments well into 2026.

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

[MARKET UPDATE] USD has been weakening in recent trade, and has seen some further downside amid constructive commentary from USTR Greer on FBN

More than 800 British defense Cos. have urged UK Chancellor Reeves to launch a global rearmament bank to guarantee lending to the sector as the UK government attempts to ramp up military spending, Politico reports

CVS Health (CVS) says utilisation is expected to persist at elevated levels in 2026, although the level is difficult to accurately predict, beyond current levels it may pressure the health care benefits segment and health care delivery assets in 2026

S&P Global Inc. (SPGI) Q4 2025 (USD): Adj. EPS 4.30 (exp. 4.33), Revenue 3.92bln (exp. 3.91bln); sees 2026 revenue +6-8%

CVS (CVS) affirms FY26 revenue of at least USD 400bln (exp. 412.1bln, prev. at least USD 400bln) and CapEx USD 3-3.2bln - earnings slides

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This may indicate potential challenges for margins and revenue growth in these areas, which investors should monitor closely for impacts on the stock's performance and overall valuation. The uncertainty in predicting future levels adds a layer of risk for stakeholders, especially in the context of broader industry dynamics.

Related headlines

The whole workspace, free to try.

Try it free